Summary
Becton, Dickinson and Company (BDX) filed an 8-K on April 25, 2007, to report its financial results for the second fiscal quarter ended March 31, 2007. The filing primarily highlights the company's use of non-GAAP financial measures to provide investors with a clearer view of its operational performance, excluding the impact of foreign currency fluctuations, insurance settlements, and specific in-process research and development (R&D) charges. Management emphasizes that these adjusted measures are used internally for performance evaluation and budgeting, and are presented to investors as a supplemental tool to better understand underlying trends and facilitate comparisons across periods. Investors should note that while these non-GAAP metrics offer insights into operational performance before certain non-recurring or currency-related impacts, they are not a substitute for GAAP results. The company explicitly advises that these adjusted figures may differ from those reported by other companies and that users should consider them in conjunction with GAAP results, acknowledging that the excluded items could materially impact reported net income and earnings per share.
Key Highlights
- 1BDX announced its Q2 fiscal year 2007 financial results on April 25, 2007.
- 2The company is providing non-GAAP financial measures alongside GAAP results.
- 3Adjusted measures include revenue growth at constant foreign exchange rates.
- 4Selling, administrative, R&D, operating income, and income from continuing operations are presented excluding the impact of insurance settlements and specific R&D charges from acquisitions (TriPath and GeneOhm).
- 5Earnings Per Share (EPS) are also adjusted to exclude these non-operational items.
- 6Management uses these non-GAAP measures for internal performance evaluation, budgeting, and to enhance period-over-period comparability for investors.
- 7The filing emphasizes that non-GAAP results are supplemental, not replacements for GAAP, and should be considered alongside GAAP figures.